<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04492579</url>
  </required_header>
  <id_info>
    <org_study_id>5642622173</org_study_id>
    <nct_id>NCT04492579</nct_id>
  </id_info>
  <brief_title>Newborns Supplemented With Gentle-UHT Donor Milk</brief_title>
  <official_title>Neonates Supplemented With Gentle-UHT Donor Human Milk in the First Week of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LactaLogics, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Renown Regional Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>LactaLogics, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effects of providing breastfeeding mothers with Gentle-UHT donor&#xD;
      human milk (GHM) after discharge to bridge the gap during delayed onset lactation, to support&#xD;
      an exclusive human milk diet and continued breastfeeding through the infant's first week of&#xD;
      life. The investigators aim to determine the safety of GHM, and if GHM provided to&#xD;
      breastfeeding mothers of outpatient babies with early weight loss will ensure babies&#xD;
      adequately gain weight according to age-matched controls.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 3, 2018</start_date>
  <completion_date type="Actual">January 17, 2020</completion_date>
  <primary_completion_date type="Actual">January 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight gain</measure>
    <time_frame>8-9 days of life</time_frame>
    <description>Average weights compared to WHO data</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exclusive human milk diet</measure>
    <time_frame>8-9 days of life</time_frame>
    <description>Rates of infants still on an exclusive human milk diet</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Newborns</condition>
  <condition>Breast Milk Expression</condition>
  <arm_group>
    <arm_group_label>Supplementation of Gentle-UHT donor milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supplementation of Gentle-UHT donor milk in addition to mother's own milk, as recommended by the health care providers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gentle-UHT donor human milk supplementation</intervention_name>
    <description>Providers referred mothers with newborns that fit the following criteria: exhibited insufficient milk supply, an infant with early weight loss born &gt;36 weeks gestation. Mother was given Gentle-UHT donor milk for supplementation, in addition to mother's own milk for the first week of the infant's life after hospital discharge.</description>
    <arm_group_label>Supplementation of Gentle-UHT donor milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Gestational age &gt;36 weeks&#xD;
&#xD;
          -  Exclusively fed human milk&#xD;
&#xD;
          -  Age &lt;96 hours (4 days)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous admittance to the neonatal intensive care unit&#xD;
&#xD;
          -  Supplementation of any formula&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca Perry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Renown Regional Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>LactaLogics, Inc.</name>
      <address>
        <city>Port Saint Lucie</city>
        <state>Florida</state>
        <zip>34952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 23, 2020</study_first_submitted>
  <study_first_submitted_qc>July 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2020</study_first_posted>
  <last_update_submitted>July 29, 2020</last_update_submitted>
  <last_update_submitted_qc>July 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

